Active — Not RecruitingPhase 4

Vital Pulp Treatment in Primary Teeth

United States76 participantsStarted 2018-07-01

Plain-language summary

In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the treatment of deep decay in children's primary molars.

Who can participate

Age range2 Years – 9 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pediatric patients with deep dental decay in primary molars * Teeth with signs and symptoms of reversible pulpitis Exclusion Criteria: * Teeth with clinical symptoms of irriversible pulpitis or pulp necrosis or acute dental infection * Children with systemic illness that contraindicated vital pulp treatment such a sickle cell disease * Teeth that are not restorable

What they're measuring

Clinical success after pulpotomy

Timeframe: 3 years

Clinical success after indirect pulp cap

Timeframe: 3 years

Radiographic success after pulpotomy

Timeframe: 3 years

Trial details

NCT IDNCT02298504

SponsorUniversity of Maryland, Baltimore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-01

View on ClinicalTrials.gov More Vital Pulp Therapies trials